Delivery Order SPE2DB22D2206-SPE2DB24FFF90
Award Date
1/24/24
Potential Completion Date
1/25/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,867.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of December 14, 2023 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,546.96 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. The award is associated with a larger Indefinite Delivery Contract...
This federal contract award, valued at $3,231.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lyrica 100 mg capsules, a medication used to treat various conditions including neuropathic pain, fibromyalgia, and seizures. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $2,736.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lyrica 50 mg capsules, a medication commonly used for the treatment of neuropathic pain, fibromyalgia, and other conditions. The contract has an ultimate completion date of January 9, 2024 and a firm fixed-price pricing structure. This award is...
This federal contract award, valued at $12,109.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a prescription medication used to treat certain types of nerve pain. The award is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This contract is not designated as a set-aside and appears to be part of a...
This federal contract award, valued at $11,508.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lyrica 50 mg capsules to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $7,286.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a medication used to treat conditions such as neuropathic pain. The contract is structured as a delivery order, with a firm fixed price pricing type and an ultimate completion date of April 10, 2025. This award is not designated as a...
This federal contract award, valued at $3,650.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FB9S6) for the supply of Lyrica 50 mg capsules, a medication used to treat nerve pain. The contract has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,732.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 75 mg capsules, a prescription medication used to treat nerve pain. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 12, 2025. It is not designated as a set-aside contract, indicating open...